Peng Hui Chen

Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong.

Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China.

CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China.

NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.

Qianglian Zhichuang (Beijing) Technology Co., Ltd. is based in Beijing, China. Qianglian Zhichuang (Beijing) Technology Co., Ltd. provides intelligent auxiliary diagnosis and treatment solutions for neurological diseases. The Chinese company was founded in 2016 by Lan Qin and Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016.